| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |